Shennon Biotechnologies
SAN FRANCISCO, California, United States · Biotechnology
ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoim
Key facts
- Headquarters
- SAN FRANCISCO, California, United States
- Employees
- 17
- Industries
- Biotechnology
- Status
- Private
- Website
- www.shennonbio.com
- Company page
Recent activity at Shennon Biotechnologies
- : Shennon Biotechnologies Appoints Cyril Konto as Chief Executive Officer
- : Shennon Biotechnologies raises $12M in financing for its precision immunotherapy pipeline and appoints Cyril Konto, M.D., as Chief Executive Officer.
- : Shennon Biotechnologies
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Shennon Biotechnologies funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2026 | Venture | $12.0M |
| Dec 2022 | Venture | $7.3M |
Leadership
- Li, Founder/CEO
- Cyril Konto, M.D., Chief Executive Officer
- JAMES HARDIMAN, Director
- LI SUN, Executive Officer
Verified email and direct lines for Shennon Biotechnologies’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
Shennon Biotechnologies files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Companies similar to Shennon Biotechnologies
- Trellis Bioscience · Biotechnology
- Kardi Ai · Biotechnology
- OpZira · Biotechnology
- ARC Medical · Biotechnology
- Concretene · Biotechnology
About Shennon Biotechnologies: questions and answers
What does Shennon Biotechnologies do?
ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoim
Where is Shennon Biotechnologies headquartered?
Shennon Biotechnologies is headquartered in SAN FRANCISCO, California, United States.
How many employees does Shennon Biotechnologies have?
Shennon Biotechnologies has about 17 employees.
Has Shennon Biotechnologies raised funding?
Yes. Fundz has recorded 2 funding events for Shennon Biotechnologies. The most recent, $12.0M, was in Sep 2026.
Who leads Shennon Biotechnologies?
Li is a Founder/CEO at Shennon Biotechnologies.
What is the latest news on Shennon Biotechnologies?
On Sep 14, 2026, Shennon Biotechnologies Appoints Cyril Konto as Chief Executive Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy